These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6180643)

  • 21. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
    Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
    Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of intrarenal ANG II in reflex neural stimulation of plasma renin activity and renal sodium reabsorption.
    Nelson LD; Osborn JL
    Am J Physiol; 1993 Aug; 265(2 Pt 2):R392-8. PubMed ID: 8368393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of acute pharmacological blockade of the renin-angiotensin system on intrarenal hemodynamics in patients with systemic lupus erythematosus and systemic scleroderma].
    Bugrova OV; Kutyrina IM; Bagirova VV; Morozova EV; Gromova MM
    Ter Arkh; 2001; 73(6):20-5. PubMed ID: 11521515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrarenal infusions of endothelin in conscious dogs: interactions with prostanoids and angiotensin II.
    Anderson WP; Heguilen RM; Woods RL
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):511-7. PubMed ID: 8569208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of influence of extra- and intrarenally formed angiotensin II on renal blood flow.
    Rassier ME; Li T; Zimmerman BG
    J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S106-10. PubMed ID: 2438483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of angiotensin-converting enzyme inhibition on altered renal hemodynamics induced by low protein diet in the rat.
    Fernández-Repollet E; Tapia E; Martínez-Maldonado M
    J Clin Invest; 1987 Oct; 80(4):1045-9. PubMed ID: 3308957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin-angiotensin system inhibition in acute myocardial infarction in dogs. Effects on systemic hemodynamics, myocardial blood flow, segmental myocardial function and infarct size.
    Liang CS; Gavras H; Black J; Sherman LG; Hood WB
    Circulation; 1982 Dec; 66(6):1249-55. PubMed ID: 6183019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
    Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
    J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Converting enzyme inhibition: implications for renal perfusion and function.
    Hollenberg NK
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():73-9. PubMed ID: 6183037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.
    Lappe RW; Todt JA; Wendt RL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):651-6. PubMed ID: 3001271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
    Westlin W; Mullane K
    Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrarenal actions of the new adenosine agonist CGS 21680A, selective for the A2 receptor.
    Levens N; Beil M; Schulz R
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1013-9. PubMed ID: 2046018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of inhibition of converting enzyme on inactive renin in the circulation of salt-replete and salt-deplete normal subjects.
    Millar JA; Hammat MT; Johnston CI
    J Endocrinol; 1980 Aug; 86(2):329-35. PubMed ID: 6253587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between angiotensin II and adenosine in mediating the vasoconstrictor response to intrarenal hypertonic saline infusions in the dog.
    Deray G; Sabra R; Herzer WA; Jackson EK; Branch RA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):631-5. PubMed ID: 2179530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of intrarenal angiotensin II in mediating renal response to volume expansion.
    Pinilla JM; Perez MC; Hernandez I; Quesada T; García-Estañ J; Salazar FJ
    Am J Physiol; 1991 Sep; 261(3 Pt 2):R619-25. PubMed ID: 1832268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal response to captopril reflects state of local renin system in healthy humans.
    Fisher ND; Price DA; Litchfield WR; Williams GH; Hollenberg NK
    Kidney Int; 1999 Aug; 56(2):635-41. PubMed ID: 10432403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin inhibitors for hypertension.
    Gavras H; Gavras I; Brunner HR
    Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of acute hemodynamic effects of MC-838, a new angiotensin-converting enzyme inhibitor, with captopril in anesthetized dogs.
    Noguchi K; Kato T; Sunagawa R; Miyamoto Y; Sakanashi M
    Jpn J Pharmacol; 1986 Mar; 40(3):373-80. PubMed ID: 3012164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.